GSK and Pfizer launch joint HIV venture, ViiV Healthcare

AIDS Treatment News  Nov 05 09

"The company says that their research will not solely focus on creating new molecules, but will try to develop new formulations that are easier to adhere to, including paediatric fixed-dose combinations. "Dominique Limet, the new chief executive, told Reuters that 'Our intent is to look at what we can do with the portfolio we get from Pfizer and Glaxo to build new combinations which will completely transform the way we treat HIV.' "The company also states that it is committed to broadening access to medicines around the world and maintaining GSK’s Positive Action programme, which supports community projects. Full story...

Bookmark and Share

Have your say - be the first to comment

Please login to post a comment


Login


More stories from aids treatment news »

Low bone mineral density common in HIV-positive men

AIDS Treatment News  4 days ago

"A large proportion of HIV-positive men have low bone mineral density, Australian researchers report in the December 1st edition of the Journal of Infectious Diseases.

Routine Screening for Depression: Identifying a Challenge for Successful HIV Care

AIDS Treatment News  4 days ago

"Given the association between depressive symptomatology and poor rates of HIV viral suppression, screening and appropriate interventions for depressive symptoms are warranted in the HIV outpatient setting to improve outcomes.

The Needle Nexus

AIDS Treatment News  5 days ago

"Needle exchange is AIDS prevention that works. While no one wants to have to put on a condom, every drug user prefers injecting with a clean needle.

Pregnancy, not nevirapine cause of liver toxicities in HIV-positive women

AIDS Treatment News  Nov 19 09

"Results of US research 'challenge the notion that nevirapine is uniquely associated with hepatotoxicity during pregnancy.

Surviving to die of something else: AIDS is a rare cause of death in old people with HIV

AIDS Treatment News  Nov 19 09

"A French study of a group of people with HIV aged over 60 has found that over a four-year period, one in seven of the group died – but not a single death was attributable to an AIDS-defining illness.

Early Treatment, Non-AIDS Disease Management Stressed in New European Guidelines

AIDS Treatment News  Nov 19 09

"Antiretroviral (ARV) therapy is now recommended for certain people living with HIV with CD4 counts between 350 and 500 cells, according to new HIV treatment guidelines released this week by the European AIDS Clinical Society (EACS).

Low Vitamin D Levels in Alpine HIV Study

AIDS Treatment News  Nov 19 09

"A new study adds to the evidence that vitamin D deficiency is common in people living with HIV. The new data, from an Italian study reported last week at the 12th European AIDS Conference in Cologne, Germany, and summarized by the National AIDS Treatment Advocacy Project (NATAP), underscore the potential importance of testing for and treating low vitamin D levels to thwart the increased risk of bone deterioration and immune system dysfunction in those infected with the virus.

Protease inhibitor monotherapy as a maintenance regimen: are we edging towards acceptance?

AIDS Treatment News  Nov 19 09

"An entire session at the 12th European AIDS Conference was devoted to trials of different ritonavir-boosted protease inhibitors (PI/r) used as the sole drug in an antiretroviral regimen.

November 23: New deadline to submit ideas for the National AIDS Strategy

AIDS Treatment News  Nov 16 09

"1. Brainstorm ideas and identify specific action steps that address the three National HIV/AIDS Strategy goals to reduce HIV incidence, increase access to care and optimize health outcomes for people living with HIV, and reduce HIV-related health disparities.

Higher Viral Loads Associated With Metabolic Syndrome

AIDS Treatment News  Nov 14 09

"People with higher HIV levels are more likely to have a cluster of symptoms—called metabolic syndrome—associated with cardiovascular disease than people with lower viral loads, according to a study published in the December [2009] issue of the Journal of Acquired Immune Deficiency Syndromes.